ID
23010
Beschrijving
Study ID: 100527 Clinical Study ID: B2E100527 Study Title: A randomised, double blind, placebo controlled, parellel group study to examine the efficacy, safety, tolerability and systemic pharmacokinetic profile of repeated inhaled doses of GSK159797 Sponsor: GlaxoSmithKline Phase: phase 2 Study Recruitment Status: Completed Generic Name: milveterol Trade Name: Milveterol Study Indication: Pulmonary Disease, Chronic Obstructive
Trefwoorden
Versies (2)
- 19-06-17 19-06-17 -
- 19-06-17 19-06-17 -
Geüploaded op
19 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Subject Diary Card (Treatment period) - GSK Milveterol COPD 100527
Subject Diary Card (Treatment period) - GSK Milveterol COPD 100527
Similar models
Subject Diary Card (Treatment period) - GSK Milveterol COPD 100527
C0087111 (UMLS CUI-2)
C1948053 (UMLS CUI-3)
C0332152 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0884980 (UMLS CUI [1,2])
C0700580 (UMLS CUI [1,3])
C1706433 (UMLS CUI [1,2])
C0884980 (UMLS CUI [1,3])
C0700580 (UMLS CUI [1,4])
C2348792 (UMLS CUI [1,5])
C1706433 (UMLS CUI [1,2])
C0439505 (UMLS CUI [1,3])
C0884980 (UMLS CUI [1,4])
C0700580 (UMLS CUI [1,5])